Analyst Research

Report Title Price
Provider: Directors Deals Ltd.
$12.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

ICU Medical Inc Lowers FY 2013 Guidance


Thursday, 18 Jul 2013 04:10pm EDT 

ICU Medical Inc announced that for fiscal 2013, it expects to generate revenue in the range of $320 million to $325 million, compared to the previous guidance of $330 million to $337 million and diluted earnings to be in the range of $2.50 to $2.60 per share, compared to the previous guidance of $2.70 to $2.85 per share. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenue of $334 million and EPS of $2.81 for fiscal 2013. 

Company Quote

83.63
-0.06 -0.07%
25 Nov 2014